Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide plus Dexamethasone in Newly Diagnosed ITP
NCT07065968Phase 2Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Aug 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of teriflunomide in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Started Aug 2025; status: recruiting.
02
Drugs
teriflunomide
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT07065968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07065968.